Collaboration with IBM to strengthen digital health expertise
“We want to increase the balance between what we call the four Ds: digital, diagnostics, devices and drugs. Today, we have a majority of companies being traditional biotechs. We want to build more around complementary skills,” says Magnus Björsne.
Invest in Gothenburg recently met Magnus to get an update on the BioVentureHub.
= = =
Photo credit: Ben Kendall, Business Region Göteborg
You are now leaving AstraZeneca BioVentureHub
You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.
Click ‘cancel’ to return to AstraZeneca’s site or ‘continue’ to proceed.
You are about to access AstraZeneca historic archive material. Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. Please refer to your approved national product label (SmPC) for current product information.
I have read this warning and will not be using any of the contained product information for clinical purposes.